home/science/Catechin
home/Community

For orders & info: 1-800-793-2601
Catechin
Description: Catechin is a bioflavonoid that is found in Green Tea. It works both alone and in conjunction with other flavonoids found in tea, and has both antiviral and antioxidant qualities.
Catechin has been shown helpful in the treatment of viral hepatitis.
1 Supplementation of 500 to 750 mg three times daily appears effective.
It also appears to prevent oxidative damage to the heart, kidney, lungs, and spleen.
2
Preliminary studies of animals show that catechin prevents oxidative damage to blood as well.
3
When taken as part of Green Tea, catechin also appears to inhibit the growth of stomach cancer cells.
4

Natural Sources: Green Tea.

Useful in treatment of: antioxidant Damage, hepatitis.

Recommended Dosage: Several cups of Green Tea daily, or supplementally 500 to 750 mg three times daily.

Contraindications: Catechin should not be taken with Iron, as the combination may cause red blood cell damage. Long-term supplementation with catechin may also cause problems.5

References:

1Suzuki H, Yamamoto S, Hirayama C, et al. Cianidanol therapy for HBs-antigen-positive chronic hepatitis: A muticentre, double-blind study. Liver 1986;6:35–44.
2Vitamin E, selenium, trolox C, ascorbic acid palmitate, acetylcysteine, coenzyme Q, beta-carotene, canthaxanthin, and catechin protect against oxidative damage to kidney, heart, lung and spleen. Free Radic Res, 22(2):177-86 1995 Feb
3Protection of vitamin E, selenium, trolox C, ascorbic acid palmitate, acetylcysteine, coenzyme Q0, coenzyme Q10, beta-carotene, canthaxanthin, and (+)-catechin against oxidative damage to rat blood and tissues in vivo. Free Radic Biol Med, 18(5):949-53 1995 May
4Induction of apoptosis in human stomach cancer cells by green tea catechins. Oncol Rep, 5(2):527-9 1998 Mar-Apr
5Salama A, Mueller-Eckhardt C. Cianidanol and its metabolites bind tightly to red cells and are responsible for the production of auto- and/or drug-dependent antibodies against these cells. Br J Haemotol 1987;66:263–66.

Back to top